Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

× No keyword cloud information.

5 in total

1. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.

Authors: J Veselý; A Pískala
Journal: Neoplasma Date: 1986 Impact factor: 2.575

2. Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.

Authors: J S Driscoll; D G Johns; J Plowman
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

3. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).

Authors: A Townsend; J M Leclerc; G Dutschman; D Cooney; Y C Cheng
Journal: Cancer Res Date: 1985-08 Impact factor: 12.701

4. Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.

Authors: M Dalal; J Plowman; T R Breitman; H M Schuller; A A del Campo; D T Vistica; J S Driscoll; D A Cooney; D G Johns
Journal: Cancer Res Date: 1986-02 Impact factor: 12.701

5. 1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.

Authors: R I Glazer; M C Knode
Journal: Mol Pharmacol Date: 1984-09 Impact factor: 4.436

5 in total

1 in total

1. A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group study.

Authors: M L Bernstein; V M Whitehead; H Grier; R Dubowy; V Land; S Devine; S Murphy; F Kung
Journal: Invest New Drugs Date: 1993-11 Impact factor: 3.850

1 in total